| Type 2 Diabetes Mellitus |
1 |
1 |
| Lipids Management |
0 |
0.9 |
| Cardiovascular Risk Management |
0 |
0.99 |
| Triglycerides |
0 |
0.72 |
| LDL Cholesterol |
0 |
0.37 |
| Clinical Guidelines |
0 |
0.36 |
| Lipoproteins |
0 |
0.36 |
| Clinical Research |
0 |
0.24 |
| Hospital |
0 |
0.24 |
| Healthcare and Medical Technology |
0 |
0.15 |
| Genomic Medicine |
0 |
0.13 |
| Biomarker |
0 |
0.12 |
| Blood |
0 |
0.12 |
| Cardiovascular disease |
0 |
0.12 |
| Epidemiology |
0 |
0.12 |
| Infarction |
0 |
0.12 |
| Plasma |
0 |
0.12 |
| Statins |
0 |
0.12 |
| Cerebrovascular Accident |
0 |
0.08 |
| Myocardial Infarction (MI) |
0 |
0.08 |